- Report
- July 2024
- 144 Pages
Global
From €2648EUR$2,990USD£2,269GBP
- Report
- July 2019
- 266 Pages
Global
From €3099EUR$3,500USD£2,656GBP
- Report
- June 2022
- 152 Pages
Global
From €4871EUR$5,500USD£4,173GBP
- Report
- December 2024
- 120 Pages
Global
From €5269EUR$5,950USD£4,515GBP
- Report
- September 2024
- 90 Pages
China
From €3099EUR$3,500USD£2,656GBP
- Report
- July 2023
- 100 Pages
Global
From €5269EUR$5,950USD£4,515GBP
- Report
- November 2022
- 100 Pages
Global
From €5269EUR$5,950USD£4,515GBP
- Report
- August 2025
- 180 Pages
Global
From €3139EUR$3,545USD£2,690GBP
€3488EUR$3,939USD£2,989GBP
- Report
- August 2025
- 187 Pages
Global
From €3139EUR$3,545USD£2,690GBP
€3488EUR$3,939USD£2,989GBP
- Report
- May 2024
- 200 Pages
Global
From €3675EUR$4,150USD£3,149GBP
- Report
- December 2024
- 150 Pages
Global
From €3321EUR$3,750USD£2,845GBP
- Report
- July 2024
- 150 Pages
Global
From €3321EUR$3,750USD£2,845GBP
- Report
- July 2024
- 100 Pages
Global
From €3321EUR$3,750USD£2,845GBP
- Report
- July 2023
- 116 Pages
Global
From €3985EUR$4,500USD£3,414GBP
- Report
- October 2022
- 117 Pages
Global
From €3985EUR$4,500USD£3,414GBP
- Report
- July 2025
- 350 Pages
Global
From €4383EUR$4,949USD£3,755GBP
- Report
- June 2025
- 400 Pages
Global
From €4383EUR$4,949USD£3,755GBP
- Report
- May 2023
- 147 Pages
Global
From €4383EUR$4,949USD£3,755GBP
- Report
- January 2024
- 143 Pages
Global
From €3764EUR$4,250USD£3,225GBP
- Report
- July 2024
- 155 Pages
Global
From €3011EUR$3,400USD£2,580GBP
€3764EUR$4,250USD£3,225GBP

The Bare Metal Stent (BMS) market is a subset of the larger stent market. BMS are medical devices used to treat narrowed or blocked arteries. They are made of stainless steel or cobalt chromium and are designed to be inserted into the artery to keep it open. BMS are used to treat a variety of conditions, including coronary artery disease, peripheral artery disease, and carotid artery disease. BMS are typically used in combination with other treatments, such as angioplasty or bypass surgery.
BMS are considered to be a cost-effective treatment option for many patients, as they are less expensive than other stent types. They are also less invasive than other treatments, making them a popular choice for many patients.
Some of the major companies in the BMS market include Abbott, Boston Scientific, Medtronic, and Biotronik. Show Less Read more